Mazda Reports June Sales Results
CPO sales totaled 5,436 vehicles in June, a decrease of 13 percent compared to
- 2nd-best June sales since 1994 with 33,385 vehicles sold.
About Mazda North American Operations
Proudly founded in
Follow @MazdaUSA on social media: Facebook, Instagram, X, YouTube, and Threads.
Month-To-Date | Year-To-Date | |||||||||
June | June | YOY % | % MTD | June | June | YOY % | % MTD | |||
2025 | 2024 | Change | DSR | 2025 | 2024 | Change | DSR | |||
Mazda3 | 1,906 | 2,670 | (28.6) % | (22.7) % | 16,946 | 17,827 | (4.9) % | (3.7) % | ||
Mazda 3 Sdn | 1,295 | 1,603 | (19.2) % | (12.5) % | 12048 | 10,189 | 18.2 % | 19.8 % | ||
Mazda 3 HB | 611 | 1,067 | (42.7) % | (38.0) % | 4898 | 7,638 | (35.9) % | (35.0) % | ||
Mazda6 | 0 | 0 | - | - | 0 | 0 | - | - | ||
MX-5 Miata | 1,244 | 776 | 60.3 % | 73.7 % | 4,772 | 4,004 | 19.2 % | 20.7 % | ||
MX-5 | 799 | 453 | 76.4 % | 91.1 % | 2560 | 1,746 | 46.6 % | 48.6 % | ||
MXR | 445 | 323 | 37.8 % | 49.3 % | 2212 | 2,258 | (2.0) % | (0.7) % | ||
CX-3 | - | 0 | - | - | - | 0 | - | - | ||
CX-30 | 3,366 | 6,772 | (50.3) % | (46.2) % | 34988 | 51,222 | (31.7) % | (30.8) % | ||
CX-5 | 13,759 | 12,120 | 13.5 % | 23.0 % | 70260 | 70,214 | 0.1 % | 1.4 % | ||
CX-9 | - | 0 | - | - | - | 4 | - | - | ||
CX-50 TTL | 8,671 | 7,798 | 11.2 % | 20.5 % | 46,914 | 35,197 | 33.3 % | 35.0 % | ||
MX-30 | 0 | 0 | - | - | - | 0 | - | - | ||
CX-70 TTL | 980 | 878 | 11.6 % | 20.9 % | 8358 | 1059 | 689.2 % | - | ||
CX-90 TTL | 3,459 | 4,682 | (26.1) % | (20.0) % | 28060 | 22959 | 22.2 % | 23.8 % | ||
CARS | 3,150 | 3,446 | (8.6) % | (1.0) % | 21,718 | 21,831 | (0.5) % | 0.8 % | ||
TRUCKS | 30,235 | 32,250 | (6.2) % | 1.6 % | 188,580 | 180,655 | 4.4 % | 5.8 % | ||
TOTAL | 33,385 | 35,696 | (6.5) % | 1.3 % | 210,298 | 202,486 | 3.9 % | 5.2 % | ||
*Selling Days | 24 | 26 | 152 | 154 | ||||||
View original content to download multimedia:https://www.prnewswire.com/news-releases/mazda-reports-june-sales-results-302495820.html
SOURCE Mazda North American Operations
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Texas Truck Barn Releases Essential Commercial Fleet Selection Criteria for North Texas Businesses
- Otsuka Receives FDA Approval for First-in-Class SIMTRIYO® (centanafadine) for the Treatment of Attention-Deficit Hyperactivity Disorder (ADHD) in Adults and Pediatric Patients Aged 6 Years and Older
- Greenberg Traurig, Attorneys Shortlisted for 2026 LMG Life Sciences Americas Awards
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share